Initially perceived as a groundbreaking departure, DCTs have transformed from a disruptive force challenging the norm to an integral concept, now widely embraced in the clinical trial landscape. Join us for this upcoming Clinical Leader Live session, where experts will explore the current landscape, highlighting the positive impact of DCTs and their transition from innovation to indispensable practice in the era of evidence generation and modern clinical trials.


Merissa Govender, Global Innovation Leader, Sanofi

Lindsay Kehoe, Senior Project Manager, Clinical Trials Transformation Initiative (CTTI)

Aneta Woroniecka-Osio, DCT Strategy Development Lead, Bayer

Dan Schell, Chief Editor, Clinical Leader